Related Experiment Video
Updated: May 20, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Antifungal efficacy of natamycin in experimental fusarium solani keratitis
Xian-Hui Dong1, Wei-Juan Gao, Xiao-Ping He
1Laboratory of Spinal Cord Injury and Rehabilitation of Chengde Medical University, Chengde 067000, Hebei Province, China.
Aim:
To evaluate the efficacy of topical administration Natamycin, which is produced by China, in an experimental rabbit model of Fusarium solani keratitis, to provide experimental basis for the application of clinical safety.
Methods:
Fusarium solani was induced in the right eye of 30 New Zealand rabbits. Forty-eight hours after inoculation, the animals were divided into 3 different treatment groups, 10 rabbit eyes of each group: Group 1 (Natamycin) treated with topical Natamycin, group 2 (Natacyn) treated with topical Natacyn, group 3 (control) treated with topical saline solution. The eyes of each group was examined clinically with slit lamp using ulcer scoring system on day 4, 10, 15, and 21 for status of healing, corneal vascularisation, iritis, hypopyon and macular nebula. The findings were recorded on day 10 and day 21.
Results:
Ulcer score on day 10, day 15, day 21: The score of Natamycin group are 1.45±0.16, 1.08±0.11, 0.70±0.40. The score of Natacyn group are 1.35±0.12, 1.10±0.12, 0.65±0.35. the score of control group are 1.30±0.08, 3.63±0.28, 3.80±0.16. Natamycin group and Natacyn group were different from control group (P<0.01). There is no difference between Natamycin group and Natacyn group. Status of healing on day 10 and day 21: The cure rate of the Natamycin group is 90% on day 10, and 100% on day 21. The cure rate of the Natacyn group is 80% on day 10, and 100% on day 21.Natamycin group and Natacyn group were different from control group (P<0.01). There is no difference between Natamycin group and Natacyn group. Corneal vascularisation, iritis, hypopyon and macular nebula on day 10 and day 21: in Natamycin group, the number of the eyes which have Corner vascularisation, iritis, hypopyon and macular nebula are 2,0,0,2. In Natacyn group, the number of the eyes which have Corner vascularisation, iritis, hypopyon and macular nebula are 1,0,0,2. In control group, the number of the eyes which have Corner vascularisation, iritis, hypopyon and macular nebula are 9,9,8,9.Natamycin group and Natacyn group were different from control group (P<0.01). There is no difference between Natamycin group and Natacyn group.
Conclusion:
Natamycin was found to be effective in fungal keratitis, similar to Natacyn, and it can stop the corner vascularisation, iritis, hypopyon and macular nebula to happen. Natamyin manufactured in China is effective against fungal keratitis, with esay availability and low toxicity in its use.
Insights
Topical Natamycin, produced in China, effectively treats experimental Fusarium solani keratitis in rabbits, matching Natacyn's efficacy. This study supports its clinical use for fungal keratitis.
Area of Science:
- Ophthalmology
- Mycology
- Pharmacology
Background:
- Fungal keratitis is a significant cause of visual impairment.
- Fusarium solani is a common fungal pathogen responsible for keratitis.
- Topical Natamycin is an established antifungal agent for fungal eye infections.
Purpose of the Study:
- To evaluate the efficacy of Chinese-manufactured topical Natamycin against Fusarium solani keratitis in a rabbit model.
- To provide an experimental basis for the clinical application and safety of topical Natamycin.
Main Methods:
- Experimental fungal keratitis was induced in New Zealand rabbits using Fusarium solani.
- Rabbits were divided into three groups: topical Natamycin, topical Natacyn, and topical saline (control).
- Clinical examinations using a slit lamp and ulcer scoring system were performed on days 4, 10, 15, and 21 to assess healing, vascularization, iritis, hypopyon, and macular nebula.
Main Results:
- Both Natamycin and Natacyn groups showed significantly reduced ulcer scores compared to the control group (P<0.01) by day 21.
- The cure rates for Natamycin and Natacyn groups reached 100% by day 21, significantly higher than the control.
- Fewer instances of corneal vascularization, iritis, hypopyon, and macular nebula were observed in the Natamycin and Natacyn groups compared to the control group (P<0.01).
Conclusions:
- Topical Natamycin is effective in treating experimental fungal keratitis, demonstrating comparable efficacy to Natacyn.
- Natamycin successfully inhibited key indicators of fungal keratitis, including corneal vascularization, iritis, hypopyon, and macular nebula.
- Chinese-manufactured Natamycin offers an effective, readily available, and low-toxicity option for managing fungal keratitis.
Related Concept Videos
Antifungal Agents
Fungal Phylum Microsporidia
